The landscape of dementia prognosis has developed significantly with the appearance of advanced biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology several years right before signs and symptoms emerge. When these technological advances depict remarkable progress in be